Pharma firm makes RSV vaccine candidate breakthrough with artificial intelligence

Published by
City AM

By Millie Turner Biopharmaceutical firm Poolbeg Pharma has found a number of RSV vaccine candidates via artificial intelligence (AI), in a landmark move in finding a treatment for the virus. The London-listed company has prioritised candidates with existing early-stage clinical data, which could be repositioned into novel treatments for RSV infection. Candidates with solid safety data in humans are well positioned to rapidly enter a clinical trial to generate early human efficacy data for RSV, the company announced on Wednesday. RSV, which inflames the smallest airways in the lungs, can be dan…

Read More

See also  Innovative Manufacturers are Investing in these Advanced Technologies

Leave a Reply